US/UK/Canada

Share

Pick a time period -
Tags ( Active)

BioStock: New CFO at Neola Medical

Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently preparing for clinical validation of Neola. BioStock has contacted David to find out more about his background and how he sees the journey that currently lies ahead.Read the full article at biostock.se : https://www.biostock.se/en/2024/08/new-cfo-at-neola-medical/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Neola’s CEO to BioStock: “We are now preparing for a clinical study in the US”

After recently receiving a CB certificate for its medical device, intensive work is now underway at Neola Medical to prepare for the clinic. As part of this, a clinical pilot study will be carried out together with a neonatal ward in Sweden. – This is a step to optimize the conditions for a successful clinical study in premature babies in the United States, CEO Hanna Sjöström tells BioStock.Read the full article at biostock.se : https://www.biostock.se/en/2024/08/neolas-ceo-we-are-now-preparing-for-a-clinical-study-in-the-us/ This is a press release

Neola’s CEO to BioStock: “The certificate is a clear sign of strength”

Neola Medical’s product Neola, developed for continuously monitoring premature infants’ lungs, has been certified according to rigorous international standards. Thus, the company has passed another milestone ahead of the US FDA application for market approval.– This demonstrates the efficiency of our structured product development process and underlines our focus on quality and patient safety, says CEO Hanna SjöströmRead the full interview with Hanna Sjöström at biostock.se: https://www.biostock.se/en/2024/06/neolas-ceo-the-certificate-is-a-clear-sign-of-strength/ This is a press

Neola’s CEO to BioStock: “The results from the usability study confirm our product”

Neola Medical’s lung monitoring is user-friendly and safe. These are the results of the usability study cunducted during the spring. – Successful study results are of great importance as we will use them as part of our upcoming FDA application for market approval in the US, says Neola CEO Hanna Sjöström.Read the full article at biostock.se : https://www.biostock.se/en/2024/04/neolas-ceo-the-results-from-the-usability-study-confirm-our-product/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Neola initiates usability study ahead of FDA approval

Lund-based Neola Medical continues to advance towards clinical studies with its lung monitoring system. The company is now starting a usability study – an important part of the process to be able to launch the product in the US. BioStock spoke to CEO Hanna Sjöström to find out more about the study.Read the full article at biostock.se : https://www.biostock.se/en/2024/03/neola-initiates-usability-study-ahead-of-fda-approval/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Neola’s rapid development recognised at JPMorgan

The 42nd edition of the JPMorgan Health Conference took place last week, and one of the participants was Neola Medical. The Swedish medtech is currently preparing its lung monitoring system for a clinical study in the US. BioStock spoke to the company’s CEO Hanna Sjöström to get her impressions from the conference.Read the full article at biostock.se : https://www.biostock.se/en/2024/01/neolas-rapid-development-recognised-at-jpmorgan/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: New European patent for Neola Medical’s disposables

Neola Medical has received a new patent approval in Europe for the Neola lung monitoring system. The patent specifically covers the probes that are attached to the chest and that enable continuous monitoring of the lungs. BioStock reached out to CEO Hanna Sjöström to find out what significance the new patent has for the project.Read the full article at biostock.se : https://www.biostock.se/en/2023/12/new-european-patent-for-neola-medicals-disposables/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Premium in Neola Medical’s directed issue

Neola Medical is in the process of establishing itself properly in the US to gear up its work with the Neola lung monitoring system. The company is now carrying out a directed share issue of 20 million SEK to finance the development and market preparations. BioStock reached out to CEO Hanna Sjöström to find out more.Read the full article at biostock.se : https://www.biostock.se/en/2023/12/premium-in-neola-medicals-directed-issue/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Neola’s CEO: “The doors open for us in the US”

Lund-based Neola Medical released its report for the third quarter last week. The company’s efforts to establish itself on the US market have begun to bear fruit and they have also presented promising clinical data that further strengthens their lung monitoring system Neola. BioStock has reached out to CEO Hanna Sjöström to get her thoughts on the past quarter and to find out what happens next.Read the full article at biostock.se : https://www.biostock.se/en/2023/11/neolas-ceo-the-doors-open-for-us-in-the-us/ This is a press release from BioStock -

BioStock: Positive results for Neola presented at prominent conference

At the recent annual jENS conference prominent neonatologists from all over Europe gathered to learn about the latest developments in the field. One of the presenters was Jurate Panaviene, who announced the results of the NIOMI study, in which Neola Medical’s medical device Neola was evaluated on 100 newborn babies. BioStock reached out to the company’s CEO Hanna Sjöström to find out more.Read the full article at biostock.se : https://www.biostock.se/en/2023/10/positive-results-for-neola-presented-at-prominent-conference/ This is a press release from

BioStock: Neola CEO sees exciting autumn ahead

As Neola Medical reports its second quarter of 2023, much of the focus is on market preparations. Intensive work is underway with technical verification studies while the company is also preparing for both a preclinical and a clinical study. BioStock contacted CEO Hanna Sjöström to find out more about how she views the development during the quarter.Read the full article at biostock.se : https://www.biostock.se/en/2023/08/neola-ceo-sees-exciting-autumn-ahead/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Neola Medical kicks off the market preparations

Neola Medical is in full swing setting the stage for its medical device. While generating interest among neonatal intensive care units around Europe, technical verification is underway for clinical studies. BioStock has contacted CEO Hanna Sjöström to find out more about her take on the beginning of 2023.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/neola-medical-kicks-off-the-market-preparations/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Clinical manager sees great interest in Neola’s medical device

A little more than a year ago she fled the war in Ukraine. Today Tetiana Kovtiukh is working as clinical manager at Lund-based medtech company Neola Medical. BioStock talked to her about her role in improving the monitoring of lungs in preterm born infants.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/clinical-manager-sees-great-interest-in-neolas-medical-device/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Neola Medical continues towards market approval

2022 was an intense year for Lund-based Neola Medical. A change of name was combined with positive clinical results, ISO certification and a successful capital raise. The company is now working to prepare the Neola lung monitoring system for launch in the US. BioStock contacted CEO Hanna Sjöström for  a comment on the year-end report released this week.Read the full article at biostock.se : https://www.biostock.se/en/2023/02/neola-medical-continues-towards-market-approval/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

BioStock: Neola Medical receives ISO certification

Neola Medical is working hard towards the goal of obtaining market approval in the US with Neola, the company’s product for monitoring the lungs of premature babies. The company have now announced that the quality management system has been certified according to ISO 13485, a milestone on the road to CE marking and market approval by the FDA in the US. BioStock contacted the company’s CEO Hanna Sjöström to find out more about what this means.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/neola-medical-receives-iso-certification/ This is a press release from

BioStock: Regulatory focus for Neola Medical

Lund-based Neola Medical can look back on an eventful period when reporting the third quarter of 2022. Positive study results and a successful capital raise provide a stable foundation for the future, where the focus will be on the regulatory work ahead of the market launch. BioStock contacted Neola Medical’s CEO Hanna Sjöström to find out more about her view of the third quarter and what she sees ahead of her for 2023.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/regulatory-focus-for-neola-medical/ This is a press release from BioStock - Connecting

BioStock: Neola Medical’s technology highlighted in prestigious Pediatric Research

Neola Medical is in full swing preparing for the market launch of its lung monitoring instrument, Neola. Recently, the technology behind the device was discussed in an article in the highly regarded scientific journal Pediatric Research. The article talks about GASMAS technology and the clinical role it can play in the monitoring and managing various respiratory complications in premature babies.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/neola-medicals-technology-highlighted-in-prestigious-pediatric-research/ This is a press release from BioStock -

BioStock: Neola Medical wants to revolutionise neonatal care

It has been just over two years since Nasdaq’s listing bell rang at Medicon Village and Neola Medical entered the stock market. A lot has happened since then and the company’s focus is now all on preparing for market launch in the US. BioStock contacted Neola Medical’s CEO Hanna Sjöström to find out more about where the company is today and how she views the journey ahead.Read the full article at biostock.se: https://www.biostock.se/en/2022/09/neola-medical-wants-to-revolutionise-neonatal-care/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe